Limited Access to Aortic Valve Procedures in Socioeconomically Disadvantaged Areas.

Authors:
David G; Bergman A; Gunnarsson C; Ryan M; Chikermane S and 2 more

Journal:
J Am Heart Assoc

Publication Year: 2024

DOI:
10.1161/JAHA.123.030569

PMCID:
PMC10926797

PMID:
38216519

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Am Heart Assoc

Abbreviation: J Am Heart Assoc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acceptability of a Text Message-Based Mobile Health Intervention to Promote Physical Activity in Ca…
Atluri N; Mishra SR; Anderson T and 5 more (2024) - Transparency Score: 5/6
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-…
de Bakker M; Scholte NTB; Oemrawsingh RM and 22 more (2024) - Transparency Score: 5/6
Advancing Cardiovascular Health Equity Globally Through Digital Technologies.
Ogungbe O; Longenecker CT; Beaton A and 6 more (2024) - Transparency Score: 3/6
A Physical Activity and Diet Just-in-Time Adaptive Intervention to Reduce Blood Pressure: The myBPm…
Golbus JR; Jeganathan VSE; Stevens R and 11 more (2024) - Transparency Score: 4/6
Arterial Stiffness and Carotid Intima-Media Thickness in Children Exposed to Smokeless Tobacco in F…
Nordenstam F; Norman M; Caidahl K and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"zip codes from 0 (least disadvantaged) to 100 (most disadvantaged). table 1"

Code Sharing
Evidence found in paper:

"Disclosures G. David, A. Bergman, C. Gunnarsson, and M. Ryan have received consultancy fees from Edwards Lifesciences. S. Chikermane, C. Thompson, and S. Clancy are employees of Edwards Lifesciences."

Evidence found in paper:

"Sources of Funding This work was supported by Edwards Lifesciences."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025